Get the Stockscreener App
1.38
6.98%
0.09
After Hours:
1.39
0.01
+0.72%
Geron Corp stock is traded at $1.38, with a volume of 7.63M.
It is up +6.98% in the last 24 hours and up +0.73% over the past month.
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
See More
Previous Close:
$1.29
Open:
$1.31
24h Volume:
7.63M
Relative Volume:
0.92
Market Cap:
$880.46M
Revenue:
$29.48M
Net Income/Loss:
$-201.19M
P/E Ratio:
-4.3125
EPS:
-0.32
Net Cash Flow:
$-216.50M
1W Performance:
-2.13%
1M Performance:
+0.73%
6M Performance:
+7.81%
1Y Performance:
-67.68%
1-Day Range:
$1.2835
$1.39
1-Week Range:
$1.26
$1.48
52-Week Range:
$1.09
$4.50
Geron Corp Stock (GERN) Company Profile
Name
Geron Corp
Sector
Industry
Phone
(650) 473-7700
Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.38 | 823.04M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Resumed | Goldman | Sell |
| May-08-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Feb-27-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Feb-26-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Initiated | H.C. Wainwright | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-09-24 | Initiated | Leerink Partners | Outperform |
| Apr-30-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-29-24 | Initiated | TD Cowen | Buy |
| Mar-15-24 | Reiterated | Needham | Buy |
| Sep-12-23 | Upgrade | Goldman | Neutral → Buy |
| Mar-28-23 | Initiated | Goldman | Neutral |
| Oct-28-22 | Initiated | Wedbush | Outperform |
| Jul-28-22 | Resumed | B. Riley Securities | Buy |
| Nov-02-21 | Initiated | Robert W. Baird | Outperform |
| Feb-18-21 | Resumed | B. Riley Securities | Buy |
| Aug-03-20 | Initiated | Stifel | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Sep-03-19 | Initiated | H.C. Wainwright | Buy |
| Aug-15-19 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-09-19 | Upgrade | Needham | Hold → Buy |
| Jan-31-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Oct-02-18 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-05-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Sep-13-16 | Reiterated | FBR & Co. | Outperform |
| Sep-13-16 | Reiterated | FBR Capital | Outperform |
| Dec-07-15 | Reiterated | Piper Jaffray | Overweight |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Jun-12-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-12-14 | Downgrade | MLV & Co | Buy → Hold |
| Dec-10-13 | Reiterated | MLV & Co | Buy |
| Dec-10-13 | Upgrade | Needham | Hold → Buy |
| Nov-08-13 | Reiterated | MLV & Co | Buy |
| Oct-16-13 | Initiated | MLV & Co | Buy |
| Aug-30-12 | Initiated | Stifel Nicolaus | Buy |
| Jun-28-12 | Initiated | Needham | Hold |
View All
Geron Corp Stock (GERN) Latest News
Geron (NASDAQ:GERN) Stock Price Down 4.8%Here's Why - MarketBeat
How strong is Geron Corporation (GON) stock earnings growthDip Buying & Verified Swing Trading Watchlist - newser.com
Is Geron Corporation stock entering bullish territory2025 Investor Takeaways & Target Return Focused Picks - newser.com
Is Geron Corporation (GON) stock ideal for retirement investorsGDP Growth & Reliable Intraday Trade Plans - newser.com
Analyzing recovery setups for Geron Corporation investorsWeekly Trend Report & AI Enhanced Execution Alerts - newser.com
What MACD trends signal for Geron Corporation (GON) stock2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Building trade automation scripts for Geron CorporationPrice Action & Risk Managed Investment Signals - newser.com
What makes Geron Corporation stock attractive to growth fundsStock Surge & Scalable Portfolio Growth Ideas - newser.com
Several Insiders Invested In Geron Flagging Positive News - simplywall.st
Geron Corp. Stock Hits Day High with Strong 7.87% Intraday Surge - Markets Mojo
Geron (NASDAQ:GERN) Stock Price Up 4.2%Should You Buy? - MarketBeat
Why institutional investors increase stakes in Geron Corporation (GON) stockPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Backtesting results for Geron Corporation trading strategies2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Is Geron Corporation (GON) stock undervalued at current priceEarnings Beat & Community Supported Trade Ideas - newser.com
Geron updates on Q4 revenue from U.S. sales of RYTELO - MSN
Nearly 1M Shares: Geron Corporation's Major Equity Grant Package Draws 16 New Biotech Talents - Stock Titan
Geron Corporation $GERN Shares Sold by Woodline Partners LP - MarketBeat
When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)? - 富途牛牛
Aug Volume: What analysts say about Geron Corporation stockJuly 2025 Rallies & Daily Profit Focused Stock Screening - خودرو بانک
Geron Corporation $GERN Shares Purchased by Exome Asset Management LLC - MarketBeat
Graham Capital Management L.P. Purchases New Shares in Geron Corporation $GERN - MarketBeat
Edmond DE Rothschild Holding S.A. Grows Holdings in Geron Corporation $GERN - MarketBeat
Hsbc Holdings PLC Trims Holdings in Geron Corporation $GERN - MarketBeat
Ally Bridge Group NY LLC Grows Position in Geron Corporation $GERN - MarketBeat
What Do Investors Think About Geron Corporation (GERN) Following Q2 Results? - MSN
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) - MSN
Geron (NASDAQ:GERN) Stock Price Up 6.1%Here's What Happened - MarketBeat
Real time pattern detection on Geron Corporation stockMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
Russell Investments Group Ltd. Decreases Stock Position in Geron Corporation $GERN - MarketBeat
Geron Corp Stock (GERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geron Corp Stock (GERN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Samuels Scott Alan | EVP, Chief Legal Officer |
Feb 27 '25 |
Buy |
1.61 |
15,000 |
24,150 |
26,682 |
| SCARLETT JOHN A | Chairman, President and CEO |
Feb 27 '25 |
Buy |
1.76 |
12,500 |
22,062 |
12,500 |
| Ziegler James | EVP, Chief Commercial Officer |
Feb 27 '25 |
Buy |
1.60 |
100,000 |
160,000 |
100,000 |
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):